Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Vivet Therapeutics
Sponsor

Vivet Therapeutics

France 80 Boulevard Haussmann, 75008 Paris, France

About the sponsor

Vivet Therapeutics is involved in clinical research for Wilson's disease, with interest in treatments aimed at correcting the underlying copper transport defect and its impact on liver function. The sponsor’s work reflects a focus on rare inherited disorders affecting metabolic regulation and organ damage.

  • Gene therapy for inherited metabolic disease
  • Hepatic disease linked to copper accumulation
  • Adult patient treatment in rare disease

The clinical portfolio includes research centered on rare genetic liver disorders and therapeutic strategies intended to address disease mechanisms at the molecular level.

About Specializations

Vivet Therapeutics runs clinical trials in conditions such as Hepato-lenticular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Hepato-lenticular degeneration

Not recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Adeno-Associated Viral Vector Serotype 3B Encoding Shortened Human Atp7B
  • Sponsor:Vivet Therapeutics

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.